Company profile
ThermoGenesis Holdings, Inc.
OTC: THMO · Healthcare · Medical - Devices
#639 of 1,418 Healthcare companies by revenue32nd-percentile growth
EA Score
——FH —DQ 54GM —SS 48
v0.1 · 25/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ market scale, Altman-Z
Methodology →Revenue TTM
$9.6M
Rev growth YoY (TTM)
-7.5%
Net income (FY)
-$18.9M
Employees
25
as of 2026-08-31
Market cap
$1.6k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$9.4M$9.4M2023
Net income-$18.9M-$18.9M2023
Operating income-$8.6M-$8.6M2023
Total assets$11.2M$11.2M2023
Liabilities$14.8M$14.8M2023
Equity-$1.7M-$1.7M2023
Revenue trend
FY2018 – FY2023 · USD
FY18
FY18
FY18
FY19
FY20
FY21
FY22
FY23
Revenue by segment
Filed disclosures · FY2023
By product
Device Revenue71%
Service19%
Exclusivity Fee8%
Clinical Revenue1%
By geography
Not disclosed.
The read
What is ThermoGenesis Holdings, Inc.’s revenue?
ThermoGenesis Holdings, Inc. booked $9.4M in FY2023 revenue, contracting 9.9% year over year — slower than 68% of Healthcare companies we track, at a -200.3% net margin.
Peers · Healthcare
Precigen, Inc.44DDelivra Health Brands Inc.55CYulong Eco-Materials Limited——Curis, Inc.53DRafarma Pharmaceuticals, Inc.71BInternational Stem Cell Corporation57CNeighbors
Sacramento →Key facts
CEOXiaochun Xu
SectorHealthcare
IndustryMedical - Devices
HeadquartersRancho Cordova, CA
ExchangeOTC: THMO
Employees25
IPO date1987-06-05
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.